Immature reticulocyte fraction is an early predictor of bone marrow recovery post chemotherapy in patients with acute leukemia

Raja-Sabudin RZ 1 , Othman A , Ahmed-Mohamed KA , Ithnin A , Alauddin H , Alias H Show all authors , Abdul-Latif Z , Das S , Abdul-Wahid FS , Hussin NH

Affiliations 

  • 1 Department of Pathology, University Kebangsaan Malaysia Medical Center, Jalan Yaacob Latif, Bandar Tun Razak 56000, Kuala Lumpur, Malaysia. Tel. +603 (9) 1455555 Ext. 5780/5356. Fax. +603 (9) 1737340. E-mail: [email protected]
Saudi Med J, 2014 Apr;35(4):346-9.
PMID: 24749130

Abstract

To establish the benefits of immature reticulocyte fraction (IRF) measurement using an automated hematology cells analyzer over absolute neutrophil count (ANC) in predicting bone marrow recovery post induction chemotherapy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications